Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Investing style at a glance · Q2 2026
- Concentrated: 24 stocks, with 69.2% of the portfolio in the 10 largest.
- Biggest sector: Information Technology (38.1% of the portfolio).
- Turnover this quarter: low — 0 new positions and 0 sold out (8 added to, 16 trimmed).
- Largest position: MA at 11.0% of the portfolio.
Worked out from this 13F only (long stock positions). ⓘConcentration: The share of a portfolio in its 10 largest positions. High = a few big bets; low = spread out. Guide ⓘTurnover: How many positions were opened or closed this quarter compared with the number held. Guide
Portfolio value over time
Reported 13F value per quarter (dashed = partial quarter)
Sector allocation
Q2 2026
- Information Technology38.1%
- Health Care37.9%
- Financials11.8%
- Communication Services5.5%
- Consumer Discretionary4.0%
- Industrials2.7%
Top holdings over time
Share of the portfolio each quarter (current top 5)
Quarter-by-quarter activity
Positions bought (new or added) vs sold (trimmed or exited)
Insights
Adds vs. trims · Q2 2026
Largest estimated dollar adds (green) and trims (red) this quarter. Click a bar to open the stock.
Sector allocation over time
Share of the reported portfolio in each sector, by quarter
Performance context
Reported 13F value vs. the S&P 500 between the same quarter-end dates, and a hypothetical “copy the top 10” strategy vs. SPY. Prices through Oct 27, 2026.
Read these numbers carefully: “Reported value change” is the change in the total value of the shares on this manager’s 13F — it is not the fund’s investment return. The total also moves when investors put money into the fund or take it out, and a 13F covers only long US-listed shares — no shorts, bonds, cash or foreign stocks — so the fund’s actual return can be higher or lower.
Reported value vs. S&P 500 (cumulative)
Hypothetical top-10 vs. SPY (cumulative)
Quarter-by-quarter numbers
| Quarter | Reported value | Value change | S&P 500 | Top-10 held | Top-10 | SPY | Coverage |
|---|---|---|---|---|---|---|---|
| Q3 2026 | $771.28M | -2.8% | +2.0% | Oct 14, 2026 – Oct 27, 2026 (open) | +4.4% | +0.0% | 100% |
| Q2 2026 | $793.82M | -5.3% | +14.9% | Jul 9, 2026 – Oct 14, 2026 | +8.7% | +2.6% | 100% |
| Q1 2026 | $838.49M | -35.0% | -4.6% | Apr 8, 2026 – Jul 9, 2026 | +11.0% | +11.5% | 100% |
| Q4 2025 | $1.29B | -6.8% | +2.3% | Jan 12, 2026 – Apr 8, 2026 | -11.9% | -2.5% | 100% |
| Q3 2025 | $1.38B | -8.7% | +7.8% | Oct 15, 2025 – Jan 12, 2026 | +3.9% | +4.8% | 100% |
| Q2 2025 | $1.52B | -0.9% | +10.6% | Jul 8, 2025 – Oct 15, 2025 | +7.5% | +7.5% | 100% |
| Q1 2025 | $1.53B | -12.8% | -4.6% | Apr 15, 2025 – Jul 8, 2025 | +7.5% | +15.7% | 100% |
Not investment advice. Hypothetical, not actual results. 13F filings arrive up to 45 days after quarter end, so anyone copying them buys late; the top-10 figures start the day after each filing was published. Reported value changes include deposits and withdrawals and are not the fund's return. Costs, taxes and positions without price data are ignored. Past performance does not predict future results. How this is calculated
Column filters
| Ticker | Company | Sector | Shares | Value ↓ | % of portfolio | Change | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| MA | Mastercard Inc (Class A) | Financials | 169.41K | $87.01M | 11.0% | Reduced | -8.6K | -4.8% | -$4.39M |
| UNH | Unitedhealth Group Inc | Health Care | 160.02K | $66.51M | 8.4% | Reduced | -121.1K | -43.1% | -$50.33M |
| VEEV | Veeva Systems Inc (Class A) | Information Technology | 317.03K | $56.26M | 7.1% | Added | +707 | +0.2% | +$125.47K |
| EW | Edwards Lifesciences Corp | Health Care | 600.23K | $54.30M | 6.8% | Reduced | -90.0K | -13.0% | -$8.14M |
| IDXX | Idexx Laboratories Inc | Health Care | 97.56K | $51.36M | 6.5% | Added | +16.7K | +20.7% | +$8.81M |
| TYL | Tyler Technologies Inc | Information Technology | 173.17K | $50.65M | 6.4% | Reduced | -9.1K | -5.0% | -$2.66M |
| WST | West Pharmaceutical Services Inc | Health Care | 138.23K | $49.62M | 6.3% | Reduced | -87.8K | -38.8% | -$31.52M |
| ISRG | Intuitive Surgical Inc | Health Care | 115.69K | $46.01M | 5.8% | Added | +17.3K | +17.6% | +$6.89M |
| ADSK | Autodesk, Inc | Information Technology | 227.68K | $44.26M | 5.6% | Added | +22.5K | +11.0% | +$4.38M |
| GOOGL | Alphabet Inc (Class A) | Communication Services | 121.43K | $43.39M | 5.5% | Reduced | -64.1K | -34.5% | -$22.89M |
| MSFT | Microsoft Corp | Information Technology | 115.13K | $42.94M | 5.4% | Reduced | -16.7K | -12.7% | -$6.23M |
| CDNS | Cadence Design Systems Inc | Information Technology | 114.32K | $42.91M | 5.4% | Reduced | -31.4K | -21.5% | -$11.77M |
| ADBE | Adobe Inc | Information Technology | 179.90K | $36.88M | 4.6% | Added | +2.9K | +1.6% | +$589.64K |
| ZTS | Zoetis Inc (Class A) | Health Care | 460.01K | $33.06M | 4.2% | Added | +141.2K | +44.3% | +$10.15M |
| CPRT | Copart Inc | Consumer Discretionary | 1.05M | $29.68M | 3.7% | Added | +983.8K | +1428.9% | +$27.73M |
| MTD | Mettler Toledo International Inc | Information Technology | 21.06K | $26.90M | 3.4% | Reduced | -1.5K | -6.6% | -$1.89M |
| ACN | Accenture plc (Class A) | Industrials | 163.64K | $20.36M | 2.6% | Reduced | -9.3K | -5.4% | -$1.16M |
| BKNG | Booking Holdings Inc | Consumer Discretionary | 12.36K | $2.20M | 0.3% | Added | +11.8K | +2027.0% | +$2.10M |
| TW | Tradeweb Markets Inc (Class A) | Financials | 19.49K | $1.94M | 0.2% | Reduced | -2.7K | -12.3% | -$272.07K |
| V | Visa Inc (Class A) | Financials | 5.62K | $1.93M | 0.2% | Reduced | -175 | -3.0% | -$60.04K |
| ADP | Automatic Data Processing Inc | Information Technology | 8.41K | $1.88M | 0.2% | Reduced | -2.4K | -22.0% | -$530.31K |
| MCO | Moodys Corp | Financials | 3.63K | $1.64M | 0.2% | Reduced | -1.1K | -23.3% | -$499.12K |
| GGG | Graco Inc | Industrials | 16.79K | $1.27M | 0.2% | Reduced | -9.5K | -36.1% | -$717.46K |
| CME | Cme Group Inc | Financials | 3.80K | $839.15K | 0.1% | Reduced | -3.4K | -47.0% | -$744.20K |
Column filters
No positions were fully sold this quarter.
13F filings on record (8)
| Quarter | Form | Filed | Type | Rows | Long value | |
|---|---|---|---|---|---|---|
| Q3 2026 | 13F-HR | Oct 13, 2026 | Original | 24 | $771.28M | SEC ↗ |
| Q2 2026 | 13F-HR | Jul 8, 2026 | Original | 24 | $793.82M | SEC ↗ |
| Q1 2026 | 13F-HR | Apr 7, 2026 | Original | 24 | $838.49M | SEC ↗ |
| Q4 2025 | 13F-HR | Jan 9, 2026 | Original | 24 | $1.29B | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 14, 2025 | Original | 22 | $1.38B | SEC ↗ |
| Q2 2025 | 13F-HR | Jul 7, 2025 | Original | 22 | $1.52B | SEC ↗ |
| Q1 2025 | 13F-HR | Apr 14, 2025 | Original | 23 | $1.53B | SEC ↗ |
| Q4 2024 | 13F-HR | Jan 16, 2025 | Original | 21 | $1.75B | SEC ↗ |